Advances in Drug Discovery of Next Generation Antibody drug and New Modalities

The evolution of antibody drugs, the front-runner in biopharmaceuticals, has been achieved through various innovations in the fields of cell and genetic engineering. Now, new innovations arising from the integration of single cell analysis, data science and analytical technologies are enabling an efficient and comprehensive understanding of structure, dynamics and function at the molecular level. This has made antibody drugs an important therapeutic option based on an essential understanding of the disease and its target, and has greatly expanded therapeutic possibilities. This innovation is also contributing to the evolution of new modalities such as nucleic acid drugs, gene therapy, and cell therapy. This presentation will share the evolution of antibody drugs to date and the innovations that have contributed to this evolution, and discuss the importance of the latest innovations and drug discovery research based on these innovations.